Disease Areas of Focus

Compounds and research programs in Discovery are at the earliest stages of research. Compounds in Exploratory Development are in preclinical or early clinical development. Full development compounds are investigational drugs that are in late-stage clinical development, have been submitted to regulatory agencies for approval, or have been approved in one major market and are pending approval in other major markets. Lifecycle Management products are among approved medicines that are driving current and future growth while continuing their clinical development to determine whether additional indications and formulations will benefit patients.

Like any other scientific endeavor, clinical testing of novel drug compounds is a complex time-consuming, resource-intensive process with no guaranteed results. But, as described here, Bristol-Myers Squibb is committed to pursuing such clinical development and, in doing so, to bringing new hope to patients.